Malignant Hematology Oncology Program

Our world-renowned experts provide precision diagnostics and individualized treatment, leading to the best outcomes for patients with blood cancers

At MedStar Health, our Malignant Hematologic Oncology program located at MedStar Georgetown University Hospital brings together world-class specialists in all types of blood cancers, including yours. When you’re diagnosed you need the expertise of an integrated team who has extensive knowledge and experience in caring for your particular disease. Part of the MedStar Georgetown Cancer Institute, we provide comprehensive, highly individualized blood cancer care using cutting-edge technology and research, including clinical trials.

Through our Malignant Hematologic Oncology program, patients benefit from:

• Rigorous expertise in treating leukemia, lymphoma, and multiple myeloma
  Blood cancers are complex and rapidly changing, which is why it’s important that you have access to experts who specialize in treating your specific type of cancer. Here, you’ll find disease specialists who focus exclusively on diagnosing and treating patients with leukemia, lymphoma, and multiple myeloma. As active researchers, our hematology oncologists are leaders in their fields, using their clinical and academic expertise to offer the highest level of care.
• Next-generation diagnostic technology
  Through next-generation sequencing, our specialists can identify each patients’ unique cancer subtype and genetic markers, gaining deeper insight into the type of cancer you have and how best to treat it.
• Precision medicine for the best patient outcomes
  Our team is at the forefront of precision medicine—a complex, highly personalized approach that considers the type of tumor, the genetics of your disease, your lifestyle, and your environment to deliver a customized treatment plan. Patients’ treatment plans are reviewed on a regular basis by a multispecialty care team that includes experts in hematology, medical oncology, pathology, and radiation oncology to monitor progress and continue to tailor the plan as needed.
• Molecular diagnostics, a critical component of identifying the right treatment
  The right treatment begins with understanding the genetic makeup of your cancer from the beginning. This enables us to provide patients with advanced therapies directed by genetic testing, including those only available in clinical trials—offering the best chance of positive outcomes.